Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
1(8%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_3
2
15%
Ph phase_2
1
8%
Ph phase_4
2
15%
Ph not_applicable
8
62%

Phase Distribution

0

Early Stage

1

Mid Stage

4

Late Stage

Phase Distribution13 total trials
Phase 2Efficacy & side effects
1(7.7%)
Phase 3Large-scale testing
2(15.4%)
Phase 4Post-market surveillance
2(15.4%)
N/ANon-phased studies
8(61.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

71.4%

5 of 7 finished

Non-Completion Rate

28.6%

2 ended early

Currently Active

1

trials recruiting

Total Trials

13

all time

Status Distribution
Active(1)
Completed(5)
Terminated(2)
Other(5)

Detailed Status

unknown5
Completed5
Withdrawn2
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
13
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (7.7%)
Phase 32 (15.4%)
Phase 42 (15.4%)
N/A8 (61.5%)

Trials by Status

recruiting18%
unknown538%
withdrawn215%
completed538%

Recent Activity

Clinical Trials (13)

Drug Details

Intervention Type
DEVICE
Total Trials
13